ADAR1 Capital Management »

Veru shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Veru (VERU) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Veru

Tip: Access up to 7 years of quarterly data

All positions including Veru held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Veru by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $75k 35k 2.14

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Veru

Alyeska Investment Group
Vanguard Group
Millennium Management
Oppenheimer & Co
GSA Capital Partners
Sheets Smith Investment Management
Geode Capital Management
Summit Financial
Ikarian Capital
BlackRock
Adage Capital Partners GP
Jane Street
Citadel Advisors
Rsm Us Wealth Management
Raymond James Financial

View all funds holding Veru